Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Tipo Año Título Fuente
Artículo2022SF3B1, RUNX1 and TP53 mutations significantly impact the outcome of patients with lower-risk myelodysplastic syndromeCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2021Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2018Evaluation of parameters related to the probability of leukemic progression in patients with lower-risk myelodysplastic syndromeCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Revisión2018Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional studyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2015Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid LeukemiaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2014Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal ProphylaxisCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2014Pharmacological Profiles of Acute Myeloid Leukemia Treatments in Patient Samples by Automated Flow Cytometry: A Bridge to Individualized MedicineCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Artículo2013Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic CategoriesCLINICAL LYMPHOMA MYELOMA & LEUKEMIA